AQR Arbitrage’s Bristol-Myers Squibb BMY Stock Holding History

AQR Arbitrage’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,093	Closed	-$495K	–	1035
2020 Q4	$495K	Buy	+8,093	New	+$498K	0.02%	667

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Arbitrage's BMY Position: Q1 2021 in Review

AQR Arbitrage sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 8,093 shares — an estimated $495K sold.

AQR Arbitrage first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $495K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

AQR Arbitrage reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 8,093 Bristol-Myers Squibb shares in Q1 2021, an estimated $495K.
AQR Arbitrage first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Bristol-Myers Squibb position peaked at $495K in Q4 2020.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.